Searched for
PURDUE PHARMA
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probeMcKinsey & Co. agreed to a $650 million settlement with the DOJ, resolving a criminal investigation into their role in advising Purdue Phar...
- McKinsey faces US criminal probe over opioids work, sources sayThe probe is focused on whether McKinsey engaged in a criminal conspiracy when advising Purdue and other pharmaceutical manufacturers on ma...
- Supreme Court weighs landmark Purdue Pharma settlement impacting opioid crisisThe Supreme Court weighs a pivotal Purdue Pharma settlement shielding the Sackler family from opioid crisis lawsuits. The $6 billion agreem...
- McKinsey to pay $230 mn in latest US opioid settlementConsulting firm McKinsey & Co has agreed to pay $230 million in its latest settlement to resolve lawsuits alleging it fueled a US opioid ep...
- Netflix’s upcoming limited series 'Painkiller': See cast, release date, time, streaming details and more"Painkiller", which is co-created by Micah Fitzerman-Blue and Noah Harpster, has been inspired by Patrick Radden Keefe's articles.
- 'Scum of the earth': Drug victims face Purdue Pharma ownersAngry, defiant and sometimes tearful, more than two dozen Americans whose lives were upended by the opioid crisis finally had their long-aw...
- What's next for Purdue Pharma after $6 billion opioid settlement?The deal replaces a previous $4.3 billion agreement, which was upended on appeal after nine attorneys general argued that the Sacklers shou...
- Bob Sternfels elected Global Managing Partner of McKinseyBob Sternfels has been elected as the global managing partner of McKinsey & Company days after partners ousted previous managing partner Ke...
- McKinsey & Co to pay $550m over role in opioid crisisMcKinsey suggested ways to “turbocharge” sales of Purdue’s OxyContin painkiller at a time when the legal market for the opioid-based medici...
- Purdue Pharma to plead guilty and pay $8.3 billion over opioidsThe settlement is likely to boost Purdue's effort to move past claims it helped spark a public-health crisis over opioids with its marketin...
- Cognizant, HCL Tech may feel the pain of US opioid lawsuitsIT services firms face hurdles due to possible client bankruptcies or cut in spending to pay settlements.
- J&J ordered to pay USD 572 million for opioid addiction crisisJ&J's shares rose about two percent to USD 130 in after-market trade following the decision.
- Lupin launches generic morphine sulfate tablets in USThe company said it has launched the morphine sulfate ER Tablets in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an ...
- Aurobindo Pharma gets USFDA nod for opioid analgesic tabletsThe approved product is a generic version of Purdue Pharma's Dilaudid tablets in the same strengths, tablets relieve moderate to severe pai...
- Lupin launches generic insomnia drug in USDrug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
- US-based Purdue Pharma extends deal with HCL TechnologiesHCL Technologies has got 3-5 years extension from US-based Purdue Pharma for its end-to-end IT infrastructure management deal.
- Purdue Pharma sues Ranbaxy over sale of cheaper pain drug in USAmerican drugmaker Purdue Pharma has sued Ranbaxy to prevent from selling low-priced version of its bestselling medicine, pain reliever Oxy...
- HCL inks deal with Purdue PharmaNoida-based technology services provider HCL Technologies on Tuesday announced a multimillion dollar deal with USbased Purdue Pharma to man...
- HCL Technologies inks multi-year deal with Purdue PharmaThe scope of this engagement covers management of two data centers and all remote locations of the client in the US, HCL Technologies said.
Load More
